James L. Rubenstein

6.6k total citations
90 papers, 4.3k citations indexed

About

James L. Rubenstein is a scholar working on Neurology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, James L. Rubenstein has authored 90 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Neurology, 59 papers in Pathology and Forensic Medicine and 53 papers in Genetics. Recurrent topics in James L. Rubenstein's work include CNS Lymphoma Diagnosis and Treatment (76 papers), Lymphoma Diagnosis and Treatment (59 papers) and Glioma Diagnosis and Treatment (47 papers). James L. Rubenstein is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (76 papers), Lymphoma Diagnosis and Treatment (59 papers) and Glioma Diagnosis and Treatment (47 papers). James L. Rubenstein collaborates with scholars based in United States, Italy and France. James L. Rubenstein's co-authors include Marc A. Shuman, Patrick Treseler, Tracy T. Batchelor, Andrés J.M. Ferreri, Soonmee Cha, Michael McDermott, Lloyd E. Damon, Ramon Barajas, Lawrence D. Kaplan and Tomoko Ozawa and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

James L. Rubenstein

88 papers receiving 4.2k citations

Peers

Countries citing papers authored by James L. Rubenstein

Since Specialization

Citations

This map shows the geographic impact of James L. Rubenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Rubenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Rubenstein more than expected).

Fields of papers citing papers by James L. Rubenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Rubenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Rubenstein. The network helps show where James L. Rubenstein may publish in the future.

Co-authorship network of co-authors of James L. Rubenstein

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Rubenstein. A scholar is included among the top collaborators of James L. Rubenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Rubenstein. James L. Rubenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BTK Degradation As a Novel Therapeutic Strategy in Relapsed CNS Lymphoma: Proof of Concept Studies in Intracranial Patient-Derived, Rodent Models 2024 ·Blood ·Jun Ma, Michael P. Randall, Ming‐Chi Lu, Lingjing Chen, Huimin Geng, (unknown), (unknown), Mark Noviski, Ryan B. Rountree, James L. Rubenstein	1
2	Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review 2024 ·Neuro-Oncology ·Lakshmi Nayak, Chetan Bettegowda, Florian Scherer, Norbert Galldiks, Manmeet S. Ahluwalia, Alexander Baraniskin, Louisa von Baumgarten, Jacoline E. C. Bromberg, Andrés J.M. Ferreri, Christian Grommes, Khê Hoang‐Xuan, (unknown), James L. Rubenstein, Roberta Rudà, Michael Weller, Susan M. Chang, Martin J. van den Bent, Patrick Y. Wen, Riccardo Soffietti	11
3	Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101 2024 ·Blood Advances ·Tracy T. Batchelor, (unknown), Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina D. Wagner‐Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein	6
4	Blood Coagulation Factor Fibrinogen in Tumor Pathogenesis of Central Nervous System B-Cell Lymphoma 2021 ·American Journal Of Pathology ·Justin Chan, Mario Merlini, (unknown), Andrew S. Mendiola, Katerina Akassoglou, James L. Rubenstein, Jae Kyu Ryu	7
5	Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC 2020 ·Journal of Investigative Dermatology ·(unknown), Chen‐Yen Yang, Linlin Wang, (unknown), (unknown), Shervin Afghani, Laura B. Pincus, Ronald Balassanian, James L. Rubenstein, Ryan M. Gill, (unknown), Frank McCormick, Mark M. Moasser, Weiyun Z. Ai	19
6	An audit of retinal lymphoma treatment at the University of California San Francisco 2019 ·Eye ·Bertil Damato, (unknown), (unknown), Armin R. Afshar, James L. Rubenstein	8
7	The Challenge of Primary Central Nervous System Lymphoma 2016 ·Hematology/Oncology Clinics of North America ·Julia Carnevale, James L. Rubenstein	34
8	Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms 2015 ·American Journal of Roentgenology ·Marc C. Mabray, Benjamin Cohen, Javier Villanueva-Meyer, Francisco Valles, Ramon Barajas, James L. Rubenstein, Soonmee Cha	35
9	Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202) 2013 ·Journal of Clinical Oncology ·James L. Rubenstein, Eric D. Hsi, Jeffrey L. Johnson, Sin‐Ho Jung, Megan O. Nakashima, Barbara Grant, Bruce D. Cheson, Lawrence D. Kaplan	320
10	Complement Activation and Intraventricular Rituximab Distribution in Recurrent Central Nervous System Lymphoma 2013 ·Clinical Cancer Research ·Cigall Kadoch, Jing Li, (unknown), Lingjing Chen, Soonmee Cha, Pamela N. Münster, Clifford A. Lowell, Marc A. Shuman, James L. Rubenstein	30
11	A Systematic Approach to the Diagnosis of Suspected Central Nervous System Lymphoma 2013 ·JAMA Neurology ·Brian J. Scott, Vanja C. Douglas, Tarık Tihan, James L. Rubenstein, S Josephson	123
12	Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI 2012 ·Clinical Cancer Research ·Matthew J. Wieduwilt, Francisco Valles, Samar Issa, Caroline Behler, James Q. Hwang, Michael McDermott, Patrick Treseler, Joan M. O’Brien, Marc A. Shuman, Soonmee Cha, Lloyd E. Damon, James L. Rubenstein	99
13	Combined Diffusion and Perfusion MR Imaging as Biomarkers of Prognosis in Immunocompetent Patients with Primary Central Nervous System Lymphoma 2012 ·American Journal of Neuroradiology ·Francisco Valles, (unknown), (unknown), Ramon Barajas, James L. Rubenstein, Soonmee Cha	53
14	Sarcoidosis of the pineal gland: an unusual presentation of neurosarcoidosis 2008 ·Journal of Neuro-Oncology ·Isaac Yang, (unknown), Michael E. Sughrue, James L. Rubenstein, Andrew W. Bollen, Andrew T. Parsa	4
15	Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment 2008 ·Leukemia & lymphoma ·James L. Rubenstein, Andrés J.M. Ferreri, Stefania Pittaluga	91
16	Insights into the biology of primary central nervous system lymphoma 2008 ·Current Oncology Reports ·Maciej M. Mrugała, James L. Rubenstein, Maurilio Ponzoni, Tracy T. Batchelor	22
17	Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma 2007 ·Journal of Clinical Oncology ·James L. Rubenstein, Jane Fridlyand, Lauren E. Abrey, Arthur Shen, Jon Karch, Endi Wang, Samar Issa, Lloyd E. Damon, Michael D. Prados, Michael McDermott, Joan M. O’Brien, Chris Haqq, Marc Shuman	243
18	Pathology and Genetics of Primary Central Nervous System and Intraocular Lymphoma 2005 ·Hematology/Oncology Clinics of North America ·James L. Rubenstein, Patrick Treseler, Joan M. O’Brien	35
19	Anti-VEGF Antibody Treatment of Glioblastoma Prolongs Survival But Results in Increased Vascular Cooption 2000 ·Neoplasia ·James L. Rubenstein, Jin Kim, Tomoko Ozawa, Michael Zhang, Manfred Westphal, Dennis F. Deen, Marc A. Shuman	394
20	Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I 1992 ·Nature ·Fabio Benfenati, Flavia Valtorta, James L. Rubenstein, Fred S. Gorelick, Paul Greengard, Andrew J. Czernik	241

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact